Ultralife Corporation (ULBI): Price and Financial Metrics

Ultralife Corporation (ULBI)

Today's Latest Price: $6.87 USD

0.03 (-0.43%)

Updated Nov 27 1:00pm

Add ULBI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 59 in Industrial - Equipment

See all "A" rated Strong Buy stocks

ULBI Stock Summary

  • The ratio of debt to operating expenses for Ultralife Corp is higher than it is for about just 15.47% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.26 for Ultralife Corp; that's greater than it is for just 15.09% of US stocks.
  • With a year-over-year growth in debt of -78.8%, Ultralife Corp's debt growth rate surpasses only 3.11% of about US stocks.
  • Stocks that are quantitatively similar to ULBI, based on their financial statements, market capitalization, and price volatility, are VIVO, SCL, CRTO, CTS, and VNDA.
  • ULBI's SEC filings can be seen here. And to visit Ultralife Corp's official web site, go to www.ultralifecorporation.com.

ULBI Stock Price Chart Interactive Chart >

Price chart for ULBI

ULBI Price/Volume Stats

Current price $6.87 52-week high $8.85
Prev. close $6.90 52-week low $4.85
Day low $6.67 Volume 40,500
Day high $7.24 Avg. volume 42,483
50-day MA $6.11 Dividend yield N/A
200-day MA $6.68 Market Cap 109.43M

Ultralife Corporation (ULBI) Company Bio

Ultralife Corporation designs, manufactures, installs, and maintains power and communications systems for government, defense, and commercial sectors worldwide. The company operates through two segments, Battery & Energy Products and Communications Systems. The company was founded in 1990 and is based in Newark, New York.

ULBI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$6.87$75.51 1007%

We started the process of determining a valid price forecast for Ultralife Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Ultralife Corp ranked in the 85th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 1012.5% on a DCF basis. As for the metrics that stood out in our discounted cash flow analysis of Ultralife Corp, consider:

  • The company's balance sheet shows it gets 97% of its capital from equity, and 3% of its capital from debt. Its equity weight surpasses that of 90.39% of free cash flow generating stocks in the Industrials sector.
  • The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately merely 12.3% of US stocks with free cash flow have a lower reliance on debt in their capital structure.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Ultralife Corp? See AENZ, FLY, HIL, CPA, and LXFR.

ULBI Latest News Stream

Event/Time News Detail
Loading, please wait...

ULBI Latest Social Stream

Loading social stream, please wait...

View Full ULBI Social Stream

Latest ULBI News From Around the Web

Below are the latest news stories about Ultralife Corp that investors may wish to consider to help them evaluate ULBI as an investment opportunity.

Ultralife Corporation's (ULBI) CEO Michael Popielec on Q2 2020 Results - Earnings Call Transcript

Ultralife Corporation (ULBI) Q2 2020 Earnings Conference Call July 30, 2020 08:30 A.M. ET Company Participants Jody Burfening - Lippert/Heilshorn & Associates, Inc. Michael D. Popielec - CEO and President Philip A. Fain - CFO, Treasurer, and Corporate Secretary Conference Call Participants Gary Siperstein - Eliot Rose Asset Management Presentation...

SA Transcripts on Seeking Alpha | August 1, 2020

Ultralife Corporation Reports Second Quarter Results

NEWARK, N.Y., July 30, 2020 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $2.3 million on revenue of $28.6 million for the second quarter ended June 30, 2020. For the second quarter of 2019, the Company reported operating income of $3.0 million on revenue of $29.4 million. “Ultralife’s second quarter adjusted earnings per share of $0.13 cents reflects the benefits of our end-market diversity and resilient business model in the face of continued business disruptions caused by the pandemic,” said Michael D. Popielec, President and Chief Executive Officer. “Our Battery and Energy Products’ medical sales and government/defense sales increased 72% and 50% year over year, respectively, and when combined with the contribution from SWE, nearly offset Com...

Yahoo | July 30, 2020

Ultralife Corporation to Report Second Quarter Results on July 30, 2020

NEWARK, N.Y., July 16, 2020 -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2020 before the market opens on.

Yahoo | July 16, 2020

Ultralife Corporation Announces Change in Location of Annual Meeting of Shareholders

Ultralife Corporation (NASDAQ:  ULBI) today announced that due to the ongoing public health impact of the coronavirus (COVID-19) pandemic and out of an abundance of caution, the location of the Annual Meeting of Shareholders to be held on July 22nd at 9:00 AM Eastern Time will be changed to the Newark, NY headquarters of Ultralife located at 2000 Technology Parkway, Newark, NY 14513. As described in the proxy materials for the Annual Meeting previously distributed, shareholders are entitled to vote at the Annual Meeting if they were a shareholder at the close of business on May 26, 2020, the record date. For additional information regarding how shareholders may vote in advance of or at the Annual Meeting, please refer to Ultralife’s proxy materials filed with the U.S. Securities and E...

Yahoo | July 7, 2020

Ultralife Corporation Announces Addition to the Russell 2000® Index

NEWARK, N.Y., June 29, 2020 -- Ultralife Corporation (NASDAQ:  ULBI) today announced it has been added to the Russell 2000® Index as part of the 2020 Russell U.S. Indexes.

Yahoo | June 29, 2020

Read More 'ULBI' Stories Here

ULBI Price Returns

1-mo 33.14%
3-mo 8.70%
6-mo -14.13%
1-year -18.89%
3-year 4.89%
5-year -1.43%
YTD -7.04%
2019 9.48%
2018 3.05%
2017 32.32%
2016 -23.37%
2015 106.39%

Continue Researching ULBI

Want to see what other sources are saying about Ultralife Corp's financials and stock price? Try the links below:

Ultralife Corp (ULBI) Stock Price | Nasdaq
Ultralife Corp (ULBI) Stock Quote, History and News - Yahoo Finance
Ultralife Corp (ULBI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8973 seconds.